During the past decade, Westmount Med Bldg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westmount Med Bldg" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Westmount Med Bldg" are "Cancer of the Prostate" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Westmount Med Bldg" in a lesser frequency.

The vast majority of trials in "Westmount Med Bldg" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Westmount Med Bldg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Westmount Med Bldg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Westmount Med Bldg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".